A novel EVIl gene family, MEL1 lacking a PR domain (MELlS) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation

被引:110
作者
Nishikata, I
Sasaki, H
Iga, M
Tateno, Y
Imayoshi, S
Asou, N
Nakamura, T
Morishita, K [1 ]
机构
[1] Miyazaki Med Coll, Dept Biochem, Miyazaki 8891692, Japan
[2] Miyazaki Med Coll, Dept Internal Med 2, Miyazaki 8891692, Japan
[3] Kumamoto Univ, Sch Med, Dept Internal Med 2, Kumamoto 860, Japan
[4] Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan
关键词
D O I
10.1182/blood-2002-12-3944
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have identified a novel gene MEL1 (MDS1/EVI1-like gene 1) encoding a zinc finger protein near the breakpoint of t(1; 3)(p36;q21)-positive human acute myeloid leukemia (AML) cells. Here, we studied the structure, expression pattern, and function of MEL1 in leukemia cells. In this study, we have identified 3 transcription start sites, 1 in exon 1 and 2 in exon 2, and 2 kinds of translation products, 170 kDa (MEL1) and 150 kDa (MEL1S). Notably, the 150-kDa band of MEL1S was detected mainly in the t(1;3)(p36;q21)-positive AML cells. By immunoblot analysis and proteolytic mapping, it is suggested that the 150-kDa band of MEL1S in the leukemia cells is translated from the internal initiation codon ATG597 in exon 4 and is mostly lacking the amino-terminal PR domain of MEL1. By the cyclic amplification and selection of targets (CASTing) method for identifying consensus sequences, it was shown that the consensus sequences of MEL1 were included in 2 different consensus sequences for DNA-binding domain 1 and 2 (D1-CONS and D2-CONS) of EVI1. In reporter gene assays, MEL1S activated transcription via binding to D2-CONS; however, the fusion of MEL1 or MEL1S to GAL4 DNA-binding domain (DBD) made them GAL4 binding site-dependent transcriptional repressors. Moreover, overexpression of MEL1S blocked granulocytic differentiation induced by granulocyte colony-stimulating factor (G-CSF) in interleukin-3 (IL-3)-dependent murine myeloid L-G3 cells, while MEL1 could not block the differentiation. Thus, it is likely that overexpression of the zinc finger protein lacking the PR domain (EVI1 and MEL1S) in the leukemia cells is one of the causative factors in the pathogenesis of myeloid leukemia. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3323 / 3332
页数:10
相关论文
共 45 条
  • [41] The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator
    Soderholm, J
    Kobayashi, H
    Mathieu, C
    Rowley, JD
    Nucifora, G
    [J]. LEUKEMIA, 1997, 11 (03) : 352 - 358
  • [42] MDS1/EVI1 enhances TGF-β1 signaling and strengthens its growth-inhibitory effect, but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TCF-β1
    Sood, R
    Talwar-Trikha, A
    Chakrabarti, SR
    Nucifora, G
    [J]. LEUKEMIA, 1999, 13 (03) : 348 - 357
  • [43] Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily
    Steele-Perkins, G
    Fang, W
    Yang, XH
    Van Gele, M
    Carling, T
    Gu, J
    Buyse, IM
    Fletcher, JA
    Liu, JS
    Bronson, R
    Chadwick, RB
    de la Chapelle, A
    Zhang, XK
    Speleman, F
    Huang, S
    [J]. GENES & DEVELOPMENT, 2001, 15 (17) : 2250 - 2262
  • [44] ESTABLISHMENT AND CHARACTERIZATION OF A HUMAN HISTIOCYTIC LYMPHOMA CELL LINE (U-937)
    SUNDSTROM, C
    NILSSON, K
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1976, 17 (05) : 565 - 577
  • [45] The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase
    Vinatzer, U
    Taplick, J
    Seiser, C
    Fonatsch, C
    Wieser, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) : 566 - 573